A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.
Uveal Melanoma|Melanoma|Metastatic Uveal Melanoma|Metastatic Melanoma
BIOLOGICAL: Lifileucel (LN-144/LN-145)
Adverse events as evaluated by CTCAE v5.0, Safety will be measured descriptively using CTCAE v5.0 for all patients who undergo surgical excision., Up to 3 years
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.